Pediatrix Medical Group Statistics
Total Valuation
MD has a market cap or net worth of $1.32 billion. The enterprise value is $1.63 billion.
Important Dates
The last earnings date was Thursday, February 20, 2025, before market open.
| Earnings Date | Feb 20, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
MD has 84.52 million shares outstanding. The number of shares has increased by 1.37% in one year.
| Current Share Class | 84.52M |
| Shares Outstanding | 84.52M |
| Shares Change (YoY) | +1.37% |
| Shares Change (QoQ) | +0.75% |
| Owned by Insiders (%) | 1.54% |
| Owned by Institutions (%) | 98.12% |
| Float | 83.18M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 10.14 |
| PS Ratio | 0.65 |
| Forward PS | 0.66 |
| PB Ratio | 1.74 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | 1.07 |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.81 |
| EV / EBITDA | 7.51 |
| EV / EBIT | 8.89 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.60, with a Debt / Equity ratio of 0.87.
| Current Ratio | 1.60 |
| Quick Ratio | 1.53 |
| Debt / Equity | 0.87 |
| Debt / EBITDA | 2.65 |
| Debt / FCF | n/a |
| Interest Coverage | 4.51 |
Financial Efficiency
Return on equity (ROE) is -12.28% and return on invested capital (ROIC) is 7.71%.
| Return on Equity (ROE) | -12.28% |
| Return on Assets (ROA) | 5.25% |
| Return on Invested Capital (ROIC) | 7.71% |
| Return on Capital Employed (ROCE) | 10.47% |
| Revenue Per Employee | $369,343 |
| Profits Per Employee | -$18,178 |
| Employee Count | 5,450 |
| Asset Turnover | 0.92 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -2.27M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +84.52% in the last 52 weeks. The beta is 1.58, so MD's price volatility has been higher than the market average.
| Beta (5Y) | 1.58 |
| 52-Week Price Change | +84.52% |
| 50-Day Moving Average | 13.97 |
| 200-Day Moving Average | 11.27 |
| Relative Strength Index (RSI) | 58.78 |
| Average Volume (20 Days) | 599,922 |
Short Selling Information
The latest short interest is 2.37 million, so 2.81% of the outstanding shares have been sold short.
| Short Interest | 2.37M |
| Short Previous Month | 2.32M |
| Short % of Shares Out | 2.81% |
| Short % of Float | 2.85% |
| Short Ratio (days to cover) | 4.87 |
Income Statement
In the last 12 months, MD had revenue of $2.01 billion and -$99.07 million in losses. Loss per share was -$1.19.
| Revenue | 2.01B |
| Gross Profit | 454.34M |
| Operating Income | 183.68M |
| Pretax Income | -267.92M |
| Net Income | -99.07M |
| EBITDA | 217.48M |
| EBIT | 183.68M |
| Loss Per Share | -$1.19 |
Full Income StatementBalance Sheet
The company has $348.51 million in cash and $662.31 million in debt, giving a net cash position of -$313.81 million or -$3.71 per share.
| Cash & Cash Equivalents | 348.51M |
| Total Debt | 662.31M |
| Net Cash | -313.81M |
| Net Cash Per Share | -$3.71 |
| Equity (Book Value) | 764.94M |
| Book Value Per Share | 8.98 |
| Working Capital | 240.92M |
Full Balance SheetCash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Full Cash Flow StatementMargins
Gross margin is 22.57%, with operating and profit margins of 9.13% and -4.92%.
| Gross Margin | 22.57% |
| Operating Margin | 9.13% |
| Pretax Margin | -5.03% |
| Profit Margin | -4.92% |
| EBITDA Margin | 10.80% |
| EBIT Margin | 9.13% |
| FCF Margin | n/a |